Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease (Q48771318)

15 February 2018

title

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease (English)

1 reference

15 February 2018

0 references

0 references

5

Van Eldik LJ

1 reference

15 February 2018

Elaine Peskind

1

object named as

Peskind ER

1 reference

15 February 2018

Murray Raskind

4

object named as

Raskind MA

1 reference

15 February 2018

author name string

Griffin WS

2

1 reference

15 February 2018

Akama KT

3

1 reference

15 February 2018

publication date

1 November 2001

1 reference

15 February 2018

Neurochemistry International

published in

1 reference

15 February 2018

volume

39

1 reference

15 February 2018

issue

5-6

1 reference

15 February 2018

page(s)

409-413

1 reference

15 February 2018

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Disulfide-linked S100 beta dimers and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

S100 beta protects hippocampal neurons from damage induced by glucose deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

1 reference

7 January 2021

Overexpression of a calcium-binding protein, S100 beta, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Glial fibrillary acidic protein and beta A4 protein deposits in temporal lobe of aging brain and senile dementia of the Alzheimer type: relation with the cognitive state and with quantitative studies of senile plaques and neurofibrillary tangles.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

S100beta induces neuronal cell death through nitric oxide release from astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Purification and characterization of a neurite extension factor from bovine brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

S-100 protein release in a range of cardiothoracic surgical procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Mechanism of glial activation by S100B: involvement of the transcription factor NFkappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

beta-Amyloid regulates gene expression of glial trophic substance S100 beta in C6 glioma and primary astrocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Proteins of the brain extracellular fluid: evidence for release of S-100 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Neuro-glial neurotrophic interaction in the S-100 beta retarded mutant mouse (Polydactyly Nagoya). I. Immunocytochemical and neurochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Normal serum concentrations of S-100 protein and changes in cerebrospinal fluid concentrations of S-100 protein during and after thoracoabdominal aortic aneurysm surgery: Is S-100 protein a biochemical marker of clinical value in detecting spinal co

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

Learning and memory in S100-beta transgenic mice: an analysis of impaired and preserved function.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900048-1

7 January 2021

10.1016/S0197-0186(01)00048-1

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018